Issue of Shares

Summary by AI BETAClose X

British American Tobacco PLC announced the issuance of 9,636 ordinary shares on October 1, 2026, under its Sharesave Scheme, which have been admitted to trading on the London Stock Exchange. Following this issuance, the company's total issued share capital as of September 30, 2026, stands at 2,157,761,532 ordinary shares with voting rights, with an additional 132,648,864 shares held in treasury. There are 1,417,845 ordinary shares remaining under the existing block admission for this purpose.

Disclaimer*

British American Tobacco PLC
01 October 2026
 

British American Tobacco p.l.c. (“the Company”)

01 October 2026


Issue of Shares

In accordance with PRM 1.6.4R, the Company (LEI: 213800FKA5MF17RJKT63) confirms that between 1 September 2026 and 30 September 2026 it has issued and allotted 9,636 ordinary shares of 25 pence each (ISIN GB0002875804) “Shares” in connection with the British American Tobacco p.l.c. Sharesave Scheme. 

The Shares were admitted to trading on the London Stock Exchange Main Market under the Company's existing block admission of shares for this purpose dated 3 March 2025 (the “Block Admission”).  1,417,845 ordinary shares (not yet in issue) remain subject to the Block Admission.

The Shares rank equally and are fully fungible with the existing issued ordinary shares of the Company.

Following this issuance of Shares, the Company confirms that as at 30 September 2026, the Company's issued share capital consisted of 2,157,761,532 Shares with voting rights and 132,648,864 Shares held in Treasury.

Nancy Jiang
Senior Assistant Company Secretary

 

Enquiries:

Media Centre

press_office@bat.com | @BATplc

Investor Relations

Victoria Buxton | IR_team@bat.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings